More Globe Newswire

View Older Stories View Newer Stories

Oct 30, 2025 08:00AM Talkspace Announces Third Quarter 2025 Results
Oct 30, 2025 08:00AM EIOTCLUB Launches Game-Changing Triply-Play Pro SIM Card: Unmatched Nationwide 5G Coverage for Dash Cams
Oct 30, 2025 08:00AM LM Funding America Announces Private Repurchase of Shares and Warrants
Oct 30, 2025 08:00AM Youxin Technology Ltd Completes Acquisition of Celnet
Oct 30, 2025 08:00AM Unplanned Downtime Costs Manufacturers Up to $852M Weekly, Exposing Critical Vulnerabilities in Industrial Resilience
Oct 30, 2025 08:00AM EagleNXT Announces Sale of eBee VISION Drones to U.S. Army’s 1st Battalion, 4th Infantry Regiment in Germany
Oct 30, 2025 08:00AM Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules
Oct 30, 2025 08:00AM GraniteShares Reaches $13 Billion in Assets Under Management.
Oct 30, 2025 08:00AM Australian Oilseeds Receives Approval to Transfer Listing to The Nasdaq Capital Market and Regains Compliance with Nasdaq Listing Requirements
Oct 30, 2025 08:00AM Consumers Are Open to AI in Healthcare if Human-Guided & Transparent, New Zyter|TruCare Survey Reveals
Oct 30, 2025 08:00AM New Sunrun Survey Finds Soaring Electricity Demand and Extreme Weather Are Fueling Homeowner Anxiety; 80% Fear Data Centers Will Drive Up Utility Prices
Oct 30, 2025 08:00AM MediBeacon to Present at the Upcoming American Society of Nephrology (ASN) Kidney Week 2025
Oct 30, 2025 08:00AM Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call
Oct 30, 2025 08:00AM New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual
Oct 30, 2025 08:00AM Arcutis Launches ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5
Oct 30, 2025 08:00AM Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups
Oct 30, 2025 08:00AM Rick Sherlund, Wall Street Legend, joins in Partnership with Wedbush Tech Investment Banking
Oct 30, 2025 08:00AM Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care
Oct 30, 2025 08:00AM Biomea Fusion to Present Poster Presentations at ObesityWeek®2025
Oct 30, 2025 08:00AM SunPower Executes Major Sales Force Expansion Following Sunder Merger
Oct 30, 2025 08:00AM Workhorse Reminds Shareholders to Vote Today FOR All Proposals
Oct 30, 2025 08:00AM Monster Beverage to Report Financial Results for 2025 Third Quarter on November 6, 2025
Oct 30, 2025 08:00AM Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus
Oct 30, 2025 08:00AM ZenaTech to Highlight Drone as a Service, AI Drone Solutions, and US Defense Initiatives at Three Upcoming Investor Conferences
Oct 30, 2025 08:00AM Rumble Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
Oct 30, 2025 08:00AM Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting
Oct 30, 2025 08:00AM Kinetic Teams Up With eero to Deliver Next-Gen Secure Home Wi-Fi
Oct 30, 2025 08:00AM Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Oct 30, 2025 08:00AM Solid Biosciences to Participate at Upcoming Investor Conferences
Oct 30, 2025 08:00AM Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
Oct 30, 2025 08:00AM 23andMe Research Institute Appoints Privacy Advisory Board
Oct 30, 2025 08:00AM Barry Hytinen Appointed to ABM’s Board of Directors
Oct 30, 2025 08:00AM Edible Garden Receives Preliminary Approval to Sell Up to $3.35 Million in Tax Credits Through NJEDA Program
Oct 30, 2025 08:00AM UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
Oct 30, 2025 08:00AM Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
Oct 30, 2025 08:00AM T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 30, 2025 08:00AM Kojamo plc’s Interim Report 1 January–30 September 2025
Oct 30, 2025 08:00AM Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
Oct 30, 2025 08:00AM Harvia will publish its Interim report for January–September 2025 on Thursday, 6 November 2025 at around 9:00 a.m. EET
Oct 30, 2025 08:00AM Municipality Finance will redeem early notes issued under its MTN programme
Oct 30, 2025 08:00AM Evaxion raises $7.2 million, extending cash runway to second half of 2027
Oct 30, 2025 08:00AM OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
Oct 30, 2025 07:55AM Ramsey Theory Group CEO Dan Herbatschek Urges Enterprises to Prepare for Post-SaaS Era as AI Agents Reshape Software Delivery and Licensing Models
Oct 30, 2025 07:55AM Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
Oct 30, 2025 07:40AM CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Rα Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 07:30AM First National Corporation Reports Record Third Quarter 2025 Earnings
Oct 30, 2025 07:30AM Lancaster Resources LiDAR Results and Field Trip Data from Lake Cargelligo Gold Project
Oct 30, 2025 07:30AM Dynacor Begins Plant Shipments to Senegal; Continues Ecuador Integration
Oct 30, 2025 07:30AM Knight Therapeutics Announces Approval and Launch of MINJUVI® (tafasitamab) in Argentina
Oct 30, 2025 07:30AM DT Midstream Reports Strong Third Quarter 2025 Results; Raises Adjusted EBITDA Guidance
View Newer Stories View Older Stories